Hospital
Galen Hospital Alaska, INC.
Galen Hospital Alaska, INC. was paid $25.11M by Medicaid between Jan 2018 and May 2021, across 163 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.
33Billing provider infoGALEN HOSPITAL ALASKA, INC.
ANCHORAGE, AK 99508
ANCHORAGE, AK 99508
33aNPI1811941883assigned 05/22/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$25.11M
24GClaims277,844
24DCodes billed163
24AFirst – last monthJan 2018 – May 2021
Compared with peers
Next to other General Acute Care Hospital providers in Alaska
Rank by total paid#8 of 10
Median peer was paid$30.98M
This provider vs. median0.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 70,599 | $7.78M | |
| 2019 | 95,582 | $9.63M | |
| 2020 | 80,286 | $5.38M | |
| 2021 | 31,377 | $2.32M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 31% | 19,288 | 16,120 | $7.80M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 17% | 21,714 | 19,237 | $4.35M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 7.5% | 2,213 | 1,947 | $1.88M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.0% | 1,968 | 1,635 | $1.25M |
| 70450 | Computed tomography, head or brain; without contrast material | 3.3% | 2,264 | 2,030 | $822K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.2% | 7,084 | 5,939 | $791K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.6% | 843 | 766 | $653K |
| G0378 | Hospital observation service, per hour | 2.6% | 1,142 | 855 | $648K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.4% | 9,005 | 7,443 | $610K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.1% | 11,223 | 9,119 | $531K |
| 71046 | Radiologic examination, chest; 2 views | 1.9% | 5,314 | 4,730 | $480K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.7% | 4,674 | 4,285 | $422K |
151 more codes
| 96375 | Therapeutic injection; each additional sequential IV push | 1.4% | 5,061 | $343K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.1% | 2,337 | $264K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,787 | $249K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,497 | $243K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 545 | $203K |
| 87631 | <1% | 1,621 | $202K | |
| 80053 | Comprehensive metabolic panel | <1% | 18,851 | $176K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,801 | $169K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,085 | $157K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,661 | $150K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,206 | $142K |
| 85027 | <1% | 23,353 | $132K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,858 | $128K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 496 | $124K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,124 | $91K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,359 | $90K |
| 70486 | <1% | 202 | $88K | |
| 96376 | <1% | 1,573 | $86K | |
| 10060 | <1% | 506 | $78K | |
| 73564 | <1% | 460 | $76K | |
| 73610 | <1% | 806 | $63K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,752 | $60K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,750 | $60K |
| 73030 | <1% | 637 | $51K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 3,353 | $48K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 415 | $48K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,004 | $46K |
| 83880 | <1% | 1,466 | $44K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 1,016 | $44K |
| 83690 | <1% | 6,988 | $44K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 917 | $44K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,107 | $44K |
| 73630 | <1% | 537 | $43K | |
| 72100 | <1% | 517 | $41K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 916 | $41K |
| 84484 | <1% | 3,907 | $39K | |
| 84703 | <1% | 5,444 | $37K | |
| 93971 | <1% | 260 | $35K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,367 | $33K |
| 73130 | <1% | 374 | $32K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 4,194 | $30K |
| C1769 | Guide wire | <1% | 112 | $28K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 201 | $28K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,347 | $27K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,446 | $27K |
| 12001 | <1% | 203 | $27K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,757 | $27K |
| 87040 | <1% | 2,480 | $25K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,956 | $22K |
| 73110 | <1% | 259 | $21K | |
| 81001 | <1% | 6,533 | $19K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,079 | $19K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,509 | $18K |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 725 | $18K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 44 | $17K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | <1% | 53 | $17K |
| 86141 | <1% | 1,289 | $14K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 46 | $13K |
| 83735 | <1% | 2,313 | $13K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 44 | $13K |
| 85379 | <1% | 1,302 | $12K | |
| 85610 | <1% | 2,942 | $11K | |
| J2704 | Injection, propofol, 10 mg | <1% | 231 | $10K |
| 84702 | <1% | 731 | $10K | |
| 90715 | <1% | 564 | $10K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 15 | $10K |
| 12011 | <1% | 72 | $10K | |
| 85730 | <1% | 1,815 | $10K | |
| 73080 | <1% | 85 | $9K | |
| 83605 | <1% | 949 | $9K | |
| 87077 | <1% | 1,096 | $9K | |
| 86850 | <1% | 1,285 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 248 | $8K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 147 | $8K |
| G0383 | Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 29 | $8K |
| 74018 | <1% | 93 | $8K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 714 | $8K |
| J1630 | Injection, haloperidol, up to 5 mg | <1% | 617 | $8K |
| 76801 | <1% | 116 | $8K | |
| 76830 | Ultrasound, transvaginal | <1% | 96 | $7K |
| 87186 | <1% | 937 | $7K | |
| 73502 | <1% | 101 | $7K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 286 | $7K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 147 | $7K |
| 82550 | <1% | 1,108 | $7K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 29 | $6K |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 296 | $6K |
| 87070 | <1% | 780 | $6K | |
| 90714 | <1% | 266 | $6K | |
| 72040 | <1% | 56 | $6K | |
| 12002 | <1% | 44 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 30 | $6K |
| 84439 | <1% | 677 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,154 | $4K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 109 | $4K |
| 82553 | <1% | 425 | $4K | |
| 83615 | <1% | 905 | $4K | |
| 86900 | <1% | 1,591 | $4K | |
| 86901 | <1% | 1,591 | $4K | |
| 73140 | <1% | 70 | $4K | |
| 80076 | <1% | 484 | $4K | |
| J2560 | Injection, phenobarbital sodium, up to 120 mg | <1% | 96 | $4K |
| 87205 | <1% | 968 | $4K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 492 | $4K |
| J8540 | Dexamethasone, oral, 0.25 mg | <1% | 168 | $4K |
| 85651 | <1% | 1,069 | $3K | |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 1,490 | $3K |
| 81003 | <1% | 1,461 | $3K | |
| 80074 | <1% | 53 | $3K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 93 | $3K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 28 | $2K |
| 73590 | <1% | 31 | $2K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 840 | $2K |
| 80061 | Lipid panel | <1% | 154 | $2K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 132 | $2K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 257 | $2K |
| 73120 | <1% | 28 | $2K | |
| 82728 | <1% | 191 | $2K | |
| 76000 | <1% | 16 | $2K | |
| 74022 | <1% | 15 | $2K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 47 | $1K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 196 | $1K |
| 71101 | <1% | 12 | $1K | |
| 87486 | <1% | 45 | $1K | |
| 87581 | <1% | 45 | $1K | |
| 82150 | <1% | 144 | $930.82 | |
| 29125 | <1% | 12 | $900.10 | |
| 73090 | <1% | 14 | $782.88 | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 48 | $775.89 |
| 87181 | <1% | 212 | $709.13 | |
| J3411 | Injection, thiamine hcl, 100 mg | <1% | 29 | $611.23 |
| 85007 | <1% | 171 | $585.86 | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 47 | $555.00 |
| 86592 | <1% | 132 | $509.45 | |
| 83970 | <1% | 12 | $484.10 | |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 14 | $373.53 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 14 | $363.78 |
| J0515 | Injection, benztropine mesylate, per 1 mg | <1% | 20 | $341.76 |
| 83540 | <1% | 80 | $316.49 | |
| 83550 | <1% | 61 | $311.46 | |
| J3490 | Unclassified drugs | <1% | 15 | $270.44 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 17 | $208.77 |
| 82248 | <1% | 13 | $60.24 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 22 | $35.99 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 17 | $24.11 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 914 | $0.00 |
| 80320 | 0% | 1,127 | $0.00 | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 0% | 63 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 29 | $0.00 |
| 80329 | 0% | 32 | $0.00 | |
| G0435 | Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening | 0% | 187 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialKENNINGTON, LYNN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Galen Hospital Alaska, INC. | Anchorage, AK | $31.75M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.